Skip to main content
IFHNOS 2026
Financial Toxicity in Head and Neck Cancer Survivorship: Evidence, Lived Experience and Advocacy on Prosthetic Rehabilitation Gaps
Verbal Presentation

Verbal Presentation

10:15 am

28 August 2026

Mezzanine M1

Concurrent Session: Allied Health and Abstracts

Themes

Default

Talk Description

Institution: Head and Neck Cancer Australia - NSW, Australia

Aims Treatment for Head and Neck Cancer (HNC) can cause significant facial disfigurement with major psychosocial, functional and financial impacts. Unlike breast or limb prostheses, no national funding scheme exists for external facial prosthetics, despite their essential role in protecting exposed tissue and restoring identity, function and quality of life. This project examined the financial burden associated with external facial prosthetics and identified priority areas for national policy reform. Methodology HANCA identified substantial funding gaps through literature on prosthetic rehabilitation, financial toxicity and out‑of‑pocket costs. An expert advisory committee of clinicians and consumers highlighted external facial prosthetics as the most immediate area for reform. HANCA implemented a national advocacy campaign, leading to an invitation from the Federal Government to submit a proposal for the May 2026 Budget. Results Evidence shows persistent financial toxicity for HNC survivors, worsened by limited access to prosthetics. HANCA’s advocacy elevated this as a critical survivorship issue and informed development of a Federal Government proposal. Budget outcomes will be presented. Conclusion Financial toxicity remains a major burden for HNC survivors. Equitable access to external facial prosthetics is now positioned as an urgent national policy priority, reinforcing the importance of survivorship care beyond treatment.
Presenters
Authors
Authors

Ms Nadia Rosin - , Ms Gemma Neary - , Ms Carolyn Smith - , Prof Bruce Ashford - , Ms Ashleigh Sharman -